Document:

Fifth Amended and Restated Investors' Rights Agreement

 Exhibit 4.2 
  
  
 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED

 INVESTORS’ RIGHTS AGREEMENT 
  
  
 DATED AS OF April 14, 2009 

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 THIS FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) dated as of April 14, 2009 (“Effective Date”) is being made and entered into by and among TeleNav, Inc., a
Delaware corporation formerly known as Televigation, Inc. (the “Company”), and the parties listed in Exhibit A hereto (the “Preferred Holders”) and the individuals listed on Exhibit B hereto
(the “Founders”) with reference to the following: 
 RECITALS 
 The following provisions form the basis for, and are hereby made a part of, this Agreement: 
 A. The Preferred Holders hold shares of Series A Preferred Stock of the Company (the “Series A Stock”),
Series B Preferred Stock (the “Series B Stock”), Series B Prime Preferred Stock (the “Series B Prime Stock”), Series C Preferred Stock (the “Series C Stock”),
Series C Prime Preferred Stock (the “Series C Prime Stock”), Series D Preferred Stock (the “Series D Stock”), and Series E Preferred Stock (the “Series E Stock”), and
possess information and registration rights pursuant to that certain Fourth Amended and Restated Investors’ Rights Agreement dated as of January 26, 2006, among the Company, the Founders and the Preferred Holders (the “Prior Rights
Agreement”). 
 B. The Company and the undersigned Founders and Preferred Holders desire to terminate the Prior Rights
Agreement and to accept the rights created pursuant hereto in lieu of the rights granted to them under the Prior Rights Agreement. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 1 

 AGREEMENT 
 NOW, THEREFORE, in consideration of the promises and mutual covenants contained in this Agreement, the undersigned hereby agree that
the Prior Rights Agreement shall be superseded and replaced in its entirety by this Agreement, and the parties to this Agreement further agree as follows: 
 Section 1. REGISTRATION RIGHTS 
 1.1 Definitions. In addition
to the capitalized terms defined elsewhere in this Agreement, the following terms shall have the meanings ascribed to them below: 
 (a) “Affiliate” shall mean a person or entity that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the person or entity specified and includes
without limitation any person or entity meeting the definition of “affiliate” set forth in Rule 405 of the Securities Act; 
 (b) “Commission” shall mean the Securities and Exchange Commission; 
 (c) “Common
Stock” shall mean shares of the Company’s common stock with a par value per share of $0.001; 
 (d)
“Company IPO” shall mean the Company’s first firm commitment underwritten initial public offering of its Common Stock pursuant to a registration statement filed with the Commission under the Securities Act; 
 (e) “Forms S-3, S-4 and S-8” shall mean the respective registration statements of the same names (including successors
thereto) prepared for filing with the Commission; 
 (f) “Founders Stock” shall mean shares of Common Stock
held or hereafter acquired by the Founders; 
 (g) “Holder” shall mean any holder or transferee pursuant to
paragraph 1.11 of outstanding Registrable Securities who acquired such Registrable Securities in a transaction or Series of transactions not involving any public offering; 
 (h) “Initiating Holder” shall mean any Holder or Holders of Registrable Securities who in the aggregate hold not less than
fifty percent (50%) of either (i) the Registrable Securities, or (ii) those Registrable Securities issuable upon conversion of the Series E Stock; 
 (i) “Preferred Stock” shall mean collectively, the Company’s Series A Stock, Series B Stock, Series B Prime Stock, Series C Stock, Series C Prime Stock,
Series D Stock and Series E Stock; 
 (j) “Qualified Public Offering” shall mean a firm commitment
underwritten public offering registered under the Securities Act, (other than a registration relating solely to a transaction under Rule 145 under the Securities Act (or any successor thereto) or to an employee benefit plan of the Corporation),
if: (i) the public offering price of the Common Stock offered therein (prior to underwriter

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 2 

 
commissions and expenses) equal or exceeds two and one-half times (2.5x) the Initial Conversion Price of the Series E Preferred Stock (as defined in the Company’s Seventh Amended and
Restated Certificate of Incorporation in effect as of the date hereof and as appropriately adjusted for stock dividends, subdivisions, splits, combinations or recapitalizations with respect to such shares), and (ii) the aggregate net proceeds
to the Corporation (before deduction for underwriter commissions and expenses) equal or exceed $50,000,000; 
 (k)
“Register” shall mean a registration effected by preparing and filing a registration statement in compliance with the Securities Act and the declaration or ordering of the effectiveness of such registration statement (such term
shall include the terms “register,” “registered” and “registration”); 
 (l) “Registrable
Securities” shall mean: (i) shares of Common Stock of the Company, issued or issuable upon conversion of the Preferred Stock held by the Preferred Holders on the date hereof or thereafter acquired by a Holder; and (ii) any shares
of Common Stock issued as (or issuable upon the exercise or conversion of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or replacement of, any of the shares referenced in
clause (i) above; provided, however, that Registrable Securities shall not mean any shares of Common Stock (A) that have previously been registered, (B) that have been sold to the public either pursuant to a registration
statement or an exemption from registration under the Securities Act (including Rule 144), (C) which have been sold in a private transaction in which the transferor’s rights under this Agreement are not assigned or (D) with
respect to which shares this Agreement has terminated pursuant to Section 1.12; and 
 (m) “Securities
Act” shall mean the Securities Act of 1933, as amended. 
 1.2 Demand Registration. 
 (a) Request for Registration. If the Company shall receive from the Initiating Holders, at any time after the date hereof, other than
during the 180 day period after the closing of the Company IPO, a written request (a “Demand Request”) that the Company effect the registration or qualification of Registrable Securities at an aggregate net offering price of not
less than $50,000,000, then the Company shall: 
 (i) promptly give written notice of the proposed registration
or qualification to all other Holders and the Founders; and 
 (ii) as soon as practicable, use best efforts to
effect such registration, or qualification (including, without limitation, filing post-effective amendments, appropriate qualifications under the applicable blue sky or other state securities laws and appropriate compliance with exemptive
regulations issued under the Securities Act and any other governmental requirements or regulations) as may be so requested and as are reasonably necessary to permit or facilitate the sale and distribution of all or such portion of such Holder’s
or Holders’ Registrable Securities as are specified in such Demand Request, together with all or such portion of

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 3 

 
the Registrable Securities of other Holders or the Founders Stock of any Founders joining in such Demand Request as are specified in a written notice given within 20 days after receipt of
written notice from the Company pursuant to clause (i) of this Section 1.2(a); provided that the Company may delay the effectiveness of such Demand Request until (A) the third year anniversary of the date hereof (in such case
without impairing its right to further delay the effectiveness of such Demand Request pursuant to clause (B) of this Section 1.2(a)(ii)), or (B) if the Demand Request is received subsequent to the third year anniversary of the date
hereof or if the Company elects to delay the effectiveness of such Demand Request pursuant to clause (A) of this Section 1.2(a)(ii), up to 90 days if the Board of Directors of the Company has determined in good faith in a written
certificate delivered to the Holders, signed by the Chairman of the Board, that such a registration would be seriously detrimental to the Company and its stockholders at such time (but no further delays after such 90 days will be permitted. The
holders of a majority of the Registrable Securities held by the Initiating Holders may withdraw the Demand Request at any time prior to the third year anniversary of the date hereof if the Company elects to delay the effectiveness of such Demand
Request pursuant to clause (A) of this Section 1.2(a)(ii), or during such 90-day period if the Company elects to delay the effectiveness of such Demand Request pursuant to clause (B) of this Section 1.2(a)(ii), in which event
they will not be deemed to have made a Demand Request hereunder); provided, however, that the Company may only delay the effectiveness of such Demand Request pursuant to clause (B) of this Section 1.2(a)(ii) once in any given twelve-month
period; and provided further, that the Company will not be obligated to take any action to effect any such registration, qualification or compliance pursuant to this Section 1.2(a) after the closing of the sale of Registrable Securities
incident to two registrations effected pursuant to Demand Requests under this Section 1.2(a) if such registrations have been declared or ordered effective; and provided further, that the Company shall not be obligated to effect a registration
pursuant to this Section 1.2(a) if it delivers a written notice, delivered to the Holders within 30 days of the receipt of a Demand Request and signed by the Chairman of the Board, stating that the Company intends to file a registration
statement for the Company IPO within 90 days of the date of such notice and, during such 90 day period, the Company continues to take commercially reasonable efforts in good faith to consummate such Company IPO. Subject to the foregoing provisions,
the Company will file a registration statement covering the securities so requested to be registered as soon as practicable, but in any event within 60 days, after receipt of the request of the Initiating Holders. 
 (b) Underwriting. If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an
underwriting, they will so advise the Company as a part of their request made pursuant to Section 1.2(a) or Section 1.2(c) and the Company will include such information in the written notice referred to in Section 1.2(a)(i). In such
event, the right to registration of any Holder pursuant to Section 1.2 or Founder pursuant to Section 1.3 will be conditioned upon such Holder’s or Founder’s participation in such underwriting and the inclusion of all or part of
such Holder’s or Founder’s securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder or Founder) to the extent provided herein. The Company will (together with all
stockholders proposing to distribute their securities through such underwriting) enter into

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 4 

 
an underwriting agreement in customary form with an underwriter selected by the Initiating Holders holding a majority of the Registrable Securities proposed to be included in the underwriting by
the Initiating Holders, but subject to the reasonable approval of the Company. Notwithstanding any other provision of this Section 1.2, if the managing underwriter(s) advises the Initiating Holders and the Company in writing that marketing
factors require a limitation of the number of shares to be underwritten, the Company will so advise all stockholders of securities that would otherwise be registered and underwritten pursuant hereto, and the number of shares included in the
registration and underwriting will be allocated, first, to the Initiating Holders, second to the Holders of Registrable Securities requesting inclusion, third, to the Company, fourth, to the Founders, and fifth, to other selling stockholders, in
each case on a pro rata basis and in proportion, as nearly as practicable, to the total number of securities offered by such stockholders at the time of filing of the registration statement. If any Holder or Founder disapproves of the terms of the
underwriting, such Holder or Founder may elect to withdraw therefrom by written notice to the Company, the underwriter and the Initiating Holders. The securities so withdrawn also will be withdrawn from registration. If shares are so withdrawn from
the registration and if the number of shares to be included in such registration previously was reduced as a result of marketing factors, then the Company shall offer to all Holders who have retained rights to include securities in the registration
the right to include additional securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among such Holders as above provided. 
 (c) Form S-3. After the Company IPO, the Company will use commercially reasonable efforts to qualify and remain eligible for
registration on Form S-3; and to that end the Company will use its best efforts to register (whether or not required by law to do so) its common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
concurrently with the effective date of the first registration under the Securities Act of any securities of the Company. After the Company has qualified for the use of Form S-3 (or any successor form), the Holders of Registrable Securities
will have the right to request up to two registrations on Form S-3 in any 12 month period (such requests will be in writing and will state the number of shares of Registrable Securities to be disposed of and the intended method of disposition
of such shares by such Holders), subject only to the following: 
 (i) The Company will not be required to effect
a registration pursuant to this Section 1.2(c): (A) within 60 days immediately following the effective date of any registration statement pertaining to securities of the Company (other than a registration of securities in a Commission
Rule 145 transaction or with respect to an employee benefit plan); (B) for a period of 90 days following the request made pursuant to this Section 1.2(c) if the Board of Directors of the Company has determined in good faith that
such a registration would be seriously detrimental to the Company and its stockholders at such time (but any further delays by the Company after the first delay of 90 days will not be permitted); or (C) more than once in any six month
period; 
 (ii) The Company will not be required to effect a registration pursuant to this Section 1.2(c)
unless the Holder or Holders requesting registration propose to dispose of outstanding Registrable Securities whose anticipated aggregate offering price, net of underwriting discounts and commissions, exceeds $500,000; and 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 5 

 (iii) The Company will give notice to all Holders of Registrable Securities
of the receipt of a request for registration pursuant to this Section 1.2(c) and will provide a reasonable opportunity for other Holders to participate in the registration. 
 Subject to the foregoing provisions, the Company will use commercially reasonable efforts to effect within 30 days the registration of all shares of Registrable Securities requested to be registered
on Form S-3 to the extent requested by the Holder or Holders thereof for purposes of disposition. 
 1.3 Incidental
Registration. 
 (a) Notice of Registration. If at any time or from time to time, the Company determines to file a
registration statement under the Securities Act relating to a proposed sale to the public of shares of the Common Stock (but excluding registrations relating solely to employees’ stock option or purchase plans or relating solely to a Commission
Rule 145 transaction), either for its own account or the account of a security holder or holders, the Company: 
 (i) promptly shall give to each Holder and Founder written notice thereof (which will include a list of the jurisdictions in which the Company intends to attempt to qualify such securities under the applicable blue sky or other state
securities laws); and 
 (ii) shall include in such registration (and any related qualification under blue sky
laws or other compliance), and in any underwriting involved therein, all the Registrable Securities or Founders Stock, as the case may be, specified in a written request or requests, made within 30 days after such written notice from the
Company, by any Holder or Founder, except as set forth in Section 1.3(b). 
 (b) Underwriting. If the registration
of which the Company gives notice is for a registered public offering involving an underwriting, the Company shall so advise the Holders and Founders as part of the written notice given pursuant to Section 1.3(a)(i). In such event the right of
any Holder or Founder to registration pursuant to this Section 1.3 will be conditioned upon participation in such underwriting and the inclusion of all or part of such Holder’s Registrable Securities or such Founder’s Founders Stock,
as the case may be, in the underwriting to the extent provided in this Agreement. All Holders and Founders proposing to distribute their securities through the underwriting will (together with the Company and the other stockholders distributing
their securities through the underwriting) enter into an underwriting agreement in customary form with the managing underwriter or underwriters selected by the Company. Notwithstanding any other provision of this Section 1.3, if the managing
underwriter advises the Company in writing that marketing factors require a limitation of the number of shares to be underwritten, the underwriter may (subject to the limitations set forth below), in the case of the Company IPO only, exclude all
Registrable Securities and Founders Stock from the registration and underwriting, or, in all other cases, limit the number of Registrable Securities and Founders Stock to be included in the

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 6 

 
registration and underwriting on a pro rata basis based on the number of Registrable Securities requested to be registered by each Holder and Founder, provided: (i) that no such limitation
will be made with respect to Registrable Securities being offered by Holders who have requested the Company to register such Registrable Securities pursuant to a mandatory registration obligation of the Company in Section 1.2 or one similar
thereto; (ii) that no securities held by persons that are not Holders will be included in the registration and underwriting; (iii) no Registrable Securities shall be excluded until all securities held by the Founders have been excluded;
and (iv) after the Company IPO, such limitation will not reduce the number of Registrable Securities to be included in the registration and underwriting to less than 25 percent of the securities proposed to be included in the registration
and underwriting unless this requirement is waived by the holders of a majority of the Registrable Securities otherwise to be included in such registration. The Company will advise all Holders and Founders participating in the registration of any
such limitation, and the number of shares of Registrable Securities or Founders Stock that may be included in the registration. If any Holder or Founder disapproves of the terms of any such underwriting, such Holder or Founder may elect to withdraw
therefrom by written notice to the Company and the underwriter. The Registrable Securities or Founders Stock so withdrawn also will be withdrawn from registration. If any shares are so withdrawn and if the number of Registrable Securities or
Founders Stock to be included in such registration previously was reduced as a result of marketing factors, then the Company shall offer to all persons who have retained the right to include securities in the registration the right to include
additional securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among the persons requesting additional inclusion as provided above. The Company, in its sole discretion,
for any reason, may abandon or postpone a proposed registration otherwise subject to this Section 1.3 or withdraw the registration statement, without liability to any Holder or Founder. 
 1.4 Registration and Selling Expenses. 
 (a) Definitions. For purposes of this Section 1, “Registration Expenses” means all expenses incurred in connection with any registration, filing, qualification or compliance
pursuant to this Section 1, including, without limitation, all registration, filing and qualification fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, blue sky fees and expenses, expenses of any regular
or special audits incidental to or required by such registration, and post-effective expenses contemplated by Section 1.5, and up to $30,000 in expenses of one special counsel to the Holders in any particular registration (which such counsel
shall be acceptable to Holders of a majority of the Registrable Securities to be included in the a registration under Section 1.3, or Initiating Holders holding a majority of the Registrable Securities held by the Initiating Holders to be
included in a registration under Section 1.2), but shall not otherwise include Selling Expenses and fees and disbursements of counsel for the Holders. “Selling Expenses” shall mean all underwriting discounts, selling
commissions and stock transfer taxes applicable to the sale of Registrable Securities or Founders Stock. 
 (b) Registration
Expenses. All Registration Expenses incurred in connection with any registration, filing or qualification under this Section 1 shall be borne by the Company. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 7 

 (c) Selling Expenses. Each of the selling Holders and/or Founders will bear all
Selling Expenses incurred in connection with any offer and sale of Registrable Securities or Founders Stock owned by such Holder or Founder pursuant to this Section 1. 
 1.5 Registration Procedures. In the case of each registration or qualification effected by the Company pursuant to this
Section 1, the Company will keep each Holder and Founder participating therein advised in writing as to the initiation of such registration or qualification and as to the completion thereof. The Company will, as expeditiously as possible:

 (a) Preparation of Registration Statement. Prepare and file with the Commission a registration statement with respect
to such Registrable Securities and use commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders owning a majority of the Registrable Securities registered thereunder (or of the
Initiating Holders owning a majority of the Registrable Securities held by the Initiating Holders registered thereunder in the case of a registration under Section 1.2), keep such registration statement effective for the lesser of 120 days
or until the Holders have informed the Company in writing that the distribution of their securities has been completed; provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holder
refrains from selling any securities included in such registration at the request of an underwriter of securities of the Company; and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on
a continuous or delayed basis, such 120-day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold, provided that Rule 415, or any successor rule under the Securities Act,
permits an offering on a continuous or delayed basis, and provided further that applicable rules under the Securities Act governing the obligation to file a post-effective amendment permit, in lieu of filing a post-effective amendment that
(x) includes any prospectus required by Section 10(a)(3) of the Act or (y) reflects facts or events representing a material or fundamental change in the information set forth in the registration statement, the incorporation by
reference of information required to be included in (x) and (y) above to be contained in periodic reports filed pursuant to Section 13 or 15(d) of the 1934 Act in the registration statement. 
 (b) Amendment and Supplements. Prepare and file with the Commission such amendments and supplements to such registration statement
and the prospectus used in connection with such registration statement, as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement. 
 (c) Copies of Prospectus. Furnish to the Holders and Founders such reasonable number of copies of a prospectus, including a
preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 
 (d) Blue Sky. Use commercially reasonable efforts to register or qualify the securities covered by such registration statement under
such other securities or Blue Sky laws of such jurisdictions as shall reasonably be requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdiction (unless the Company is already subject to service in such state or jurisdiction). 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 8 

 (e) Underwriting Agreement. In the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering. Each Holder or Founder participating in such underwriting shall also enter into and perform its
obligations under such an agreement, including furnishing any customary opinion of counsel or entering into a lock-up agreement reasonably requested by the managing underwriter. 
 (f) Subsequent Events. Notify each Holder or Founder of securities covered by such registration statement, at any time when a
prospectus relating thereto covered by such registration statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing and promptly file and, at the
request of any such seller, furnish to such seller a reasonable number of copies of, a supplement to or amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such prospectus shall not
include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances then existing. 
 (g) Legal Opinions and Comfort Letters. Furnish, at the request of any Holder or Founder requesting registration of securities
pursuant to this Section 1, on the date that such securities are delivered to the underwriters for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters on the date that the
registration statement with respect to such securities becomes effective: (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given by company
counsel to the underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders and Founders requesting registration of securities, if any; and (ii) a letter dated such date, from the independent
certified public accountant of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders and
Founders requesting registration of securities, if any. 
 (h) Listing. Apply for listing and use its best efforts to
list the securities being registered on any national securities exchange on which a class of the Company’s equity securities are listed or, if the Company does not have a class of equity securities listed on a national securities exchange,
apply for qualification and use commercially reasonable efforts to qualify the securities being registered for inclusion on the automated quotation system of the National Association of Securities Dealers, Inc. 
 (i) Transfer Agent. Provide a transfer agent and registrar for all Registrable Securities registered hereunder and a CUSIP number for
all such Registrable Securities, in each case not later than the effective date of such registration. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 9 

 (j) Other. Otherwise use its best efforts to comply with all applicable rules and
regulations of the Commission, and make available to its security holders, as soon as reasonably practicable, an earning statement covering the period of at least 12 months, but not more than 18 months, beginning with the first month after
the effective date of the Registration Statement, which earnings statement shall conform materially with the provisions of Section 11(a) of the Securities Act. 
 (k) Cooperation. In the event of any underwritten public offering, cooperate with the Holders requesting registration pursuant to this Section, the underwriters participating in the offering and
their counsel in any due diligence investigation reasonably requested by the Holders or the underwriters in connection therewith, and participate, to the extent reasonably requested by the managing underwriter for the offering or the Holders, in
efforts to sell the Registrable Securities under the offering (including without limitation, participating in “roadshow” meetings with prospective investors) that would be customary for underwritten primary offerings of a comparable amount
of equity securities by the Company. 
 1.6 Indemnification. 
 (a) Company Indemnification. The Company will indemnify each Holder of Registrable Securities, each of its officers, directors,
stockholders, agents, attorneys and current and former partners and members, and each person controlling any such person within the meaning of Section 15 of the Securities Act, and each Founder, with respect to which registration, qualification
or compliance has been effected pursuant to this Section 1 and each underwriter, if any, and each person who controls (within the meaning of Section 15 of the Securities Act) any underwriter of the Registrable Securities held by or
issuable to such Holder, against all claims, losses, damages, costs, expenses and liabilities whatsoever (or actions, proceedings or settlements in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a
material fact contained in any prospectus, offering circular or other documents (including any related registration statement, notification or the like) incident to any such registration, qualification or compliance, or based on any omission (or
alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or any violation by the Company of the Securities Act or any state securities law or of any rule or
regulation promulgated under the Securities Act or any state securities law applicable to the Company and relating to action or inaction required of the Company in connection with any such registration, qualification or compliance (any such
misstatement or omission, a “Violation”), and will reimburse each such Holder, each of its officers, directors, stockholders, agents, attorneys and current and former partners and members, and each person who controls any such
person, each Founder, each such underwriter and each person who controls any such underwriter for any legal and any other expenses reasonably incurred and as incurred in connection with investigating or defending any such claim, loss, damages, cost,
expense, liability or action, provided that the Company will not be liable in any such case to the extent that any such claim, loss, damage, cost, expense or liability arises out of or is based on any Violation based upon written information
furnished to the Company by an instrument duly executed by any Holder, Founder, underwriter or other otherwise indemnified person and stated to be specifically for use in such prospectus, offering circular or other document, unless such Holder,
Founder or underwriter timely provided to the Company additional information to correct the previously inaccurate or incomplete information. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 10 

 (b) Holder/Founder Indemnification. Each Holder and each Founder will, individually
and not jointly, if Registrable Securities or Founders Stock held by such Holder or Founder are included in the securities as to which a registration or qualification is being effected, will indemnify the Company, each of its directors and officers
who sign such registration statement, each underwriter, if any, of the Company’s securities covered by such a registration statement, each person who controls the Company or such underwriter within the meaning of Section 15 of the
Securities Act, and each other Holder and each of their officers, directors, agents, attorneys and current and former partners and members and each person controlling such other Holder, against all claims, losses, damages, costs, expenses and
liabilities whatsoever (or actions, proceedings or settlements in respect thereof) arising out of or based on any Violation, and will reimburse the Company, such other Holders, such directors, officers, agents, attorneys, partners, persons or
underwriters for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, cost, expense, liability or action, in each case to the extent, but only to the extent, that such
Violation is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by an instrument duly executed by such Holder or Founder and
stated to be specifically for use therein; provided that, the foregoing indemnity agreement is subject to the condition that, insofar as it relates to any Violation made in the preliminary prospectus but eliminated or remedied in the amended
prospectus on file with the Commission at the time the registration statement becomes effective or the supplemented or amended prospectus filed with the Commission pursuant to Rule 424 under the Securities Act (the “Final
Prospectus”), such indemnity agreement will not inure to the benefit of any underwriter or any other Holder, if a copy of the Final Prospectus was not furnished to the person or entity asserting the loss, liability, claim, or damage at or
prior to the time such action is required by the Securities Act; provided further, that in no case shall any Holder be required to indemnify any person hereunder for any amount in excess of the amount of net proceeds received by such Holder from the
offering of the securities. 
 (c) Indemnification Procedures. Each party entitled to indemnification under this
Section 1.6 (the “Indemnified Party”) will give notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to
which indemnity may be sought, and will permit the Indemnifying Party to assume the defense of any litigation resulting therefrom, provided that counsel for the Indemnifying Party, who will conduct the defense of such claim or litigation, will be
approved by the Indemnified Party (whose approval will not unreasonably be withheld). After notice from the Indemnifying Party to such Indemnified Party of its election so to assume the defense thereof, the Indemnifying Party will not be liable to
such Indemnified Party under this Section 1.6 for any legal or other expenses subsequently incurred by such Indemnified Party in connection with the defense thereof, subject to the following sentence. The Indemnified Party will have the right
to employ its counsel in any such action, but the fees and expenses of such counsel will be at the expense of such Indemnified Party unless: (i) the employment of counsel by such Indemnified Party has been authorized in writing by the
Indemnifying Party; (ii) the Indemnified Party shall have been advised by its counsel that representation of such Indemnified Party and the Indemnifying Party by

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 11 

 
the same counsel would be inappropriate under applicable standards of professional conduct due to actual or potential conflicts of interest between them in the conduct of the defense of such
action (in which case the Indemnifying Party will not have the right to direct the defense of such action on behalf of the Indemnified Party); or (iii) the Indemnifying Party will not in fact have employed counsel to assume the defense of such
action, within a reasonable time, and in any of the cases set forth in (i), (ii) or (iii) above, such fees and expenses shall be paid by the Indemnifying Party. The failure to notify an Indemnifying Party within a reasonable time of the
commencement of any such action, only if prejudicial to its ability to defend such action, will relieve such Indemnifying Party of any liability to the Indemnified Party under this Section 1.6. The Indemnifying Party will not be liable, in
connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances, for the reasonable fees and expenses of more than one separate firm of attorneys for
such Indemnified Party or controlling person, which firm will be designated in writing by the Indemnified Party to the Indemnifying Party. No Indemnifying Party, in the defense of any such claim or litigation, will, except with the consent of an
Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to
such claim or litigation. If any such Indemnified Party will have been advised by counsel chosen by it that there may be one or more legal defenses available to such Indemnified Party that are different from or additional to those available to and
that have not been asserted by the Indemnifying Party, then the Indemnifying Party will not have the right to continue the defense of such action on behalf of such Indemnified Party and will reimburse such Indemnified Party and any person
controlling such Indemnified Party for the reasonable fees and expenses of any counsel retained by the Indemnified Party. The indemnity agreements contained in this Section 1.6 will not apply to amounts paid in settlement of any loss, claim,
damage, liability, or action if such settlement is effected without the consent of the Indemnifying Party (which consent will not be unreasonably withheld) as to any action the defense of which has been assumed by such Indemnifying Party.

 (d) Contribution. If recovery is not available under the foregoing indemnification provisions of this
Section 1.6, for any reason other than as specified therein, the parties entitled to indemnification by the terms thereof shall be entitled to contribution for liabilities and expenses from the parties liable for indemnification, except to the
extent that such contribution is not permitted under Section 11(f) of the Securities Act. In determining the amount of contribution to which the respective parties are entitled, there shall be considered the relative fault of the Indemnifying
Party on the one hand and of the Indemnified Party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations. The relative fault
of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information
supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative knowledge and access to information concerning the matter with respect to which the claim was asserted and the opportunity to correct and prevent any
statement of omission. The parties agree that it would not be equitable if the amount of such contribution were determined by pro rata or per capita allocation. In no event will any Holder be required to contribute an amount in excess of the amount
of net proceeds received by the Holder from the offering of the securities. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 12 

 1.7 Information by Holder/Founder. Each Holder of Registrable Securities
included in any registration, and each Founder participating in a registration, will furnish to the Company such information regarding such Holder or Founder and the distribution proposed by such Holder or Founder as the Company may reasonably
request in writing in connection with any registration or qualification referred to in this Section 1. 
 1.8
Rule 144 Reporting. With a view to making available to the Preferred Holders and Founders the benefits of certain rules and regulations of the Commission that may permit the sale of Registrable Securities to the public without
registration, the Company agrees to: 
 (a) Public Information. Make and keep public information available, as those
terms are understood and defined in Commission Rule 144, at all times after ninety days after the effective date of the first registration filed by the Company that involves a sale of securities of the Company to the general public; 

(b) Reports. File with the Commission in a timely manner all reports and other documents required of the Company under the
Securities Act and Exchange Act after it has become subject to such reporting requirements; and 
 (c) Annual and Quarterly
Reports. Furnish to any Preferred Holder so long as such Preferred Holder owns any Registrable Securities forthwith upon request a written statement by the Company that it has complied with the reporting requirements of said Commission
Rule 144 (at any time after the 90 days after the effective date of said first registration statement filed by the Company), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting
requirements), a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed by the Company as may be reasonably requested in availing any Preferred Holder of any rule or regulation of the
Commission permitting the selling of any such securities without registration. 
 1.9 Limitations on Subsequent
Registration Rights. From and after the date hereof, the Company will not, without the prior written consent of holders of at least a majority of the Registrable Securities issuable upon conversion of the Series E Stock, voting as one class,
enter into any agreement with any holder or prospective holder of any security of the Company that allows such holder or prospective holder of any securities of the Company to (i) initiate any Company registration; or (ii) include such
securities in any registration of the Company’s securities unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of his securities
will not diminish the number of Registrable Securities that are included. 
 1.10 Market Stand-Off. If requested
by the Company and the managing underwriter of common stock (or other securities) of the Company, no Holder or Founder shall sell or otherwise transfer, make any short sale, grant any option for the purchase, or enter into any hedging or similar
transaction with the same economic effect as a sale, of any common stock (or other securities) of the

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 13 

 
Company held by the Holder or Founder (other than those included in the registration) during the one hundred eighty (180) day period following the effective date of the Company IPO (or such
other period, not to exceed 18 days after the expiration of the 180-day period) as may be requested by the Company or the managing underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research
reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), provided that (1) all
executive officers and directors of the Company and holders of at least 1% of the Company’s voting securities enter into similar agreements and (2) this restriction shall not apply to any shares sold to an underwriter pursuant to an
underwriting agreement hereunder. The obligations described in this Section 1.10 shall not apply to (i) any registration following the Company IPO, (ii) a registration relating solely to employee benefit plans on Form S-l or Form S-8 or
similar forms that may be promulgated in the future and (iii) a registration relating solely to a transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose stop-transfer instructions and may stamp
each such certificate with a legend with respect to the shares of common stock (or other securities) subject to the foregoing restriction until the end of such period. The Holder or Founder agrees to execute a market standoff agreement with the
underwriters in customary form consistent with the provisions of this Section 1.10. 
 1.11 Transfer of Registration
Rights. Incident to the sale or other transfer of Registrable Securities, Holders may transfer their registration rights under this Section 1 to a transferee who: (i) holds, immediately following the transfer, at least 50,000 shares of
Registrable Securities (based upon common equivalents, and as adjusted for stock splits, stock dividends, combinations, recapitalizations and similar transactions); (ii) is a partner, a retired partner, member, former member, stockholder,
equity holder, officer, family member or trust for the benefit of any individual Holder or other Affiliate of the transferor Holder; or (iii) has received all Registrable Securities then held by the Holder; provided that such transferee agrees
to be bound by the terms and conditions of the registration rights contained herein. 
 1.12 Termination of Registration
Rights. The rights granted under this Section 1 will terminate when all Registrable Securities can be sold under Rule 144 of the Securities Act during any 90-day period. 
 Section 2. INFORMATION RIGHTS 
 2.1 Annual Reports. The
Company will deliver to each Holder holding at least 1,000,000 shares of Preferred Stock or any shares of Series E Stock (or, in either case, Common Stock issuable upon conversion of Preferred Stock or Series E Stock, and each as adjusted for stock
splits, stock dividends, combinations, recapitalizations and similar transactions), within 90 days of the end of each fiscal year, audited annual financial statements of the Company prepared by a nationally recognized accounting firm in reasonable
detail, including a balance sheet, a statement of operations and a statement of cash flows for such year, setting forth in each case in comparative form the corresponding figures for the previous fiscal year and accompanied by a report thereon by
the Company’s independent certified public accountants, which audit report shall state that such financial statements present fairly the financial position of the Company as of such date and the results of operations and cash flows for the
period indicated, all in conformity with generally accepted accounting principles, consistently applied (“GAAP”). 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 14 

 2.2 Quarterly Reports. The Company shall provide each Holder holding at least
1,000,000 shares of Preferred Stock or any shares of Series E Stock (or, in either case, Common Stock issuable upon conversion of Preferred Stock or Series E Stock, and each as adjusted for stock splits, stock dividends, combinations,
recapitalizations and similar transactions), within 45 days following the end of each fiscal quarter, unaudited financial statements of the Company, including a balance sheet, and a statement of operations and a statement of cash flows for such
fiscal quarter and the fiscal year to date, setting forth in comparative form the corresponding figures for the corresponding period of the previous fiscal year, in each case prepared in accordance with GAAP (subject to normal year-end adjustments
and without footnotes of any kind), and certified on behalf of the Company by the chief financial officer and chief executive officer of the Company. These obligations will terminate upon the Qualified IPO. 
 2.3 Monthly Reports. The Company shall provide each Holder holding at least 15,000,000 shares of Preferred Stock or any shares
of Series E Stock (or Common Stock issuable upon conversion of Preferred Stock, and as adjusted for stock splits, stock dividends, combinations, recapitalizations and similar transactions) (a “Preemptive Rights Holder”), as soon as
practicable after the end of each calendar month, monthly financial statements setting forth in comparative form against the Company’s then existing budget, prepared in accordance with GAAP (subject to normal year-end adjustments and without
footnotes of any kind) and operational updates comparing actual performance to the Company’s annual budget. 
 2.4
Other Information. The Company shall provide each Preemptive Rights Holder: (i) at least 30 days prior to the commencement of the Company’s fiscal year, an annual budget and strategic plan; and (ii) such information relating to
the financial condition, business, prospects or corporate affairs of the Company as such Preemptive Rights Holder may from time to time reasonably request in writing (provided that the Company shall not be obligated to provide any information which
it reasonable considers to be a trade secret the disclosure of which the Board of Directors of the Company reasonably believes may adversely affect its business). 
 2.5 Termination of Information Rights. The Company’s obligation to deliver financial statements under this Section 2 will terminate on the closing of the Qualified Public Offering.

 2.6 Inspection. The Company shall permit any Preemptive Rights Holder, at such Preemptive Rights Holder’s
expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by such
Preemptive Rights Holder; provided, however, that the Company shall not be obligated pursuant to this Section 2.6 to provide access to any information that the Board of Directors of the Company reasonably considers to be a trade secret or
similar confidential information the disclosure of which the Company reasonably believes may adversely affect its business. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 15 

 2.7 Assignment of Rights of Information. The rights granted pursuant to
Sections 2.1, 2.2, 2.3, 2.4 and 2.6 may be assigned by each Preemptive Rights Holder to any transferee who receives registration rights pursuant to Section 1.11; provided that such transferee holds at least at least the minimum number of
shares of Preferred Stock such transferee would have to hold to receive such rights hereunder had such transferee been a Holder as of the date of this Agreement and agrees to become subject to the obligations of the transferring Preemptive Rights
Holder hereunder. Notwithstanding the foregoing, such rights may not be assigned to a transferee if the Board of Directors of the Company reasonably determines the transferee to be a competitor of the Company. 
 Section 3. PREEMPTIVE RIGHTS. 
 3.1 Calculation of Securities Subject to Right of First Refusal. If the Company proposes to issue, in a transaction or Series of related transactions, Common Stock or any other securities exercisable for or convertible into Common
Stock or any other equity securities of the Company (including, without limitation, options, warrants, rights or convertible debt) (“New Securities”), then each Preemptive Rights Holder (as defined in Section 2.3) shall have
the right to purchase that amount of the New Securities as will enable such holder to maintain the same percentage equity ownership in the Company after the completion of the sale as before such sale on a “fully-diluted” basis (such number
of shares is referred to herein as the Preemptive Rights Holder’s “Pro Rata Share”). Such right shall not apply to: (i) securities offered to the public in a firm commitment underwritten public offering pursuant to a
registration statement filed under the Securities Act; (ii) an issuance of New Securities in connection with a stock split or distribution of a stock dividend, or pursuant to any recapitalization, reorganization, consolidation or merger for
purposes of reincorporation; (iii) an issuance of New Securities in connection with the Company effectuating or entering into a merger, joint venture, equipment leasing transaction or other commercial institutional financing transaction
approved by the Board and undertaken for other than primarily equity financing purposes; (iv) an issuance of New Securities in connection with investments in the Company made by strategic investors in connection with a bona fide business
arrangement related to the Company’s business and approved by the Board; (v) an issuance of securities upon the exercise or conversion of New Securities, the original issuance of which was subject to the rights set forth in this
Section 3; (vi) an issuance of Common Stock upon conversion of the Preferred Stock; (vii) an issuance of New Securities to employees, directors or consultants pursuant to Board approval, up to a maximum of 90,510,859 shares of Common
Stock (as adjusted for any subsequent stock dividends, combinations, subdivisions, splits or recapitalizations with respect to such shares); (viii) any issuance of Preferred Stock prior to the date of this Agreement; and (ix) any issuance
of warrants and convertible promissory notes prior to the date of this Agreement (collectively, “Excepted New Issuances”). The term “fully-diluted” as used herein shall mean treating all outstanding options, warrants and
rights to purchase equity securities of the Company as exercised and all securities convertible into Common Stock as converted. 
 3.2 Procedure. 
 (a) Notice. If the Company proposes to issue any New Securities, the Company shall first
send to each Preemptive Rights Holder, by first class mail or other certifiable manner, a plan of issuance (the “Plan”). The Plan shall set forth: (i) the Pro Rata Share

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 16 

 
of each type of New Securities that may be issued to each Preemptive Rights Holder pursuant to the Right Offer (as hereinafter defined); (ii) the name and address of each person or entity
other than Preferred Holders to whom the Company may issue any New Securities; (iii) the number of each type of New Securities that may be issued to each such person or entity; (iv) the price for, and material terms under which each such
person or entity may acquire such New Securities; (v) with respect to each type of New Securities, an offer (the “Right Offer”) to issue and sell to each Preemptive Rights Holder such Preemptive Rights Holder’s Pro Rata
Share of such New Securities (plus any overallotments for Participating Holders, as described below); and (vi) a statement explaining in detail how the Pro Rata Share of such Preemptive Rights Holder was calculated. 
 (b) Preemptive Right Period. Each Preemptive Rights Holder shall have the option, during the period commencing on the date that it
receives the Plan and continuing until 15 days thereafter, inclusive (the “Preemptive Rights Period”), to purchase all or any portion of the New Securities offered to it pursuant to the Right Offer for the price and upon the
terms specified in the Plan; provided, however, that the Preemptive Rights Holders who elect to purchase their full Pro Rata Share of the New Securities (the “Participating Holders”) will be entitled to purchase up to the full
amount of the New Securities not purchased by those Preemptive Rights Holders who do not purchase their full Pro Rata Share of the New Securities, such New Securities to be allocated among the Participating Holders on a pro rata basis. Immediately
upon the expiration of the Preemptive Rights Period, the Company shall be free for a period of 120 days thereafter to issue any New Securities not purchased by the Preferred Holders pursuant to the Right Offer (the “Unpurchased New
Securities”). The Company may decide, in its sole discretion, whether to issue all or any portion of the Unpurchased New Securities and the manner in which it allocates such Unpurchased New Securities. Notwithstanding the foregoing, the
Company shall not: (i) issue more than the maximum number of each type of New Securities that may be issued pursuant to the Plan less the number of such New Securities, if any, purchased by Preferred Holders pursuant to the Right Offer;
(ii) issue any Unpurchased New Securities to any person or entity after expiration of the 120-day period provided in this Section 3.2(b); or (iii) issue any Unpurchased New Securities during such 120-day period to any person or entity
for a lower price or upon terms more favorable to the potential purchaser than those set forth in the Plan. For purposes of this Section 3.2(b), any New Securities shall be deemed issued upon the date that the Company becomes obligated under
any agreement to issue a definite and certain number of such New Securities to a specific person. 
 3.3 Exercise of
Option. Any preemptive right specified in this Section 3 may be exercised by a Preemptive Rights Holder by the delivery of written notice to the Company within the time period required to exercise such right as set forth above. Such notice
shall be deemed delivered upon personal delivery to the Company or upon the deposit of such notice, properly addressed and bearing proper and sufficient postage, in the United States mail or with any other carrier. 
 3.4 Closing. The closing at which any New Securities purchased pursuant to a Right Offer shall be transferred to a Preemptive Rights
Holder shall be held within 30 days of the expiration of the Preemptive Rights Period. At such closing, the Company shall deliver to the exercising Preemptive Rights Holder the certificates or other documents representing the New Securities
purchased by such Preemptive Rights Holder, and such holder shall pay the Company the purchase price for such securities. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 17 

 3.5 Legends. The Company may affix to the certificates representing or include in any
other document embodying the New Securities so issued any legend(s) that it is reasonable, proper and equitable to affix or include in light of applicable laws and regulations. 
 3.6 Non-Conforming Issuance Void; Exceptions. Any attempted issuance of any securities in violation of the terms, conditions and
restrictions of this Section 3 shall be void, and, in the event of an attempted issuance of any securities in violation of this Agreement, the Company shall not (a) treat on its books any such securities as issued or (b) treat any
person or entity as the owner of, or accord any person or entity voting, dividend or other rights with respect to, such securities. 
 3.7 Transferability of Rights. The preemptive rights set forth in this Section 3 may not be assigned or transferred, except that (i) such rights are assignable by each Preemptive Rights Holder to any wholly owned subsidiary
or parent of, or to any corporation or entity that is, within the meaning of the Securities Act, controlling, controlled by or under common control with, any such Preemptive Rights Holder, (ii) such rights are assignable by each Preemptive
Rights Holder to any partner, former partner, member, retired member, stockholder or Affiliate of such Preemptive Rights Holder, and (iii) such rights are assignable between and among any of the Preemptive Rights Holders. 
 3.8 Termination of Rights. All rights under this Section 3 shall terminate (a) on the first date on which no shares of
Preferred Stock remain outstanding or (b) immediately before the closing of a Qualified Public Offering. 
 Section 4. FIRST REFUSAL AND
CO-SALE RIGHTS. 
 4.1 Rights of First Refusal and Co-Sale. 
 (a) Notice. If any Founder proposes to sell to any person or entity any of its shares of Common Stock, then the Preemptive Rights
Holders shall have a right of first refusal and right of co-sale on the terms described in this Section 4. For purposes of this Section 4, the Founder proposing such a sale shall be referred to as the “Selling Founder.” At
least 20 days before the proposed closing date of any transfer of such shares, the Selling Founder shall give a written notice (the “Notice”) to the Company and to each of the Preemptive Rights Holders at its address as shown
on the Company’s records. The Notice shall describe in detail the proposed sale, including the number of shares proposed to be transferred (the “Target Shares”), the transfer price or consideration to be paid and the name and
address of the proposed transferee. 
 (b) Company Right of First Refusal. The Company (or its assignees) shall, for a
period of twenty (20) days following receipt of the Notice, have the right to repurchase any or all of the Target Shares specified in the Notice upon substantially the same terms and conditions specified therein. Such right shall be exercisable
by delivery of written notice (the “Company Exercise Notice”) to the Selling Founder prior to the expiration of the twenty (20) day exercise period. If such right is exercised with respect to all the

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 18 

 
Target Shares specified in the Notice, then the Company (or its assignees) shall effect the repurchase of the Target Shares, including payment of the purchase price, not more than five
(5) business days after delivery of the Company Exercise Notice; and at such time the Selling Founder shall deliver to the Company the certificates representing the Target Shares to be repurchased, each certificate to be properly endorsed for
transfer. 
 (c) Preemptive Rights Holder Right of Second Refusal. If the Company declines to exercise its first refusal
right with respect to any Target Shares, it must so notify each Preemptive Rights Holder in writing upon the expiration of such rights pursuant to Section 4.1(b) above with respect to any Target Shares, and then the Preemptive Rights Holders
shall have the right, for a period of fifteen (15) days after receipt of the Company’s written notice that the Company has declined to exercise such rights with respect to any such Target Shares, to purchase such unpurchased Target Shares
at the same price and on the same terms as those set forth in the Notice (the “Secondary Refusal Right”). Each Preemptive Rights Holder may exercise the Secondary Refusal Right and, thereby, purchase all or any portion of his or its
Pro Rata Portion (as defined below and any reallotments as provided below) of the Target Shares, by notifying the Selling Founder and the Company in writing, before expiration of the fifteen (15) day period as to the number of such Target
Shares that he or it wishes to purchase. If any prospective transferee identified in the Notice has offered to pay for any Target Shares with property, services or any other non-cash consideration, then the Preemptive Rights Holders shall
nevertheless have the right to pay for such Target Shares with cash in an amount equal to the fair market value of the non-cash consideration offered by the prospective transferee in question, where the fair market value of such non-cash
consideration shall be conclusively determined in good faith by the Board. For the purposes of this Agreement, the term “Pro Rata Portion” shall mean that number of shares of Common Stock equal to the product obtained by multiplying
(i) the aggregate number of Target Shares covered by the Notice (less any shares of Target Shares purchased by the Company pursuant to its first refusal right) by (ii) a fraction, the numerator of which is the number of shares of capital
stock of the Company owned by the Preemptive Rights Holder at the time of the sale or transfer, and the denominator of which is the total number of shares of capital stock of the Company owned by all Preemptive Rights Holders at the time of the
Notice. If any Preemptive Rights Holder fails to purchase such Preemptive Rights Holder’s Pro Rata Portion pursuant to this Section 4.1(c), the Selling Founder shall give notice of such failure (the “Overallotment Notice”)
to each other Preemptive Rights Holder who is purchasing such Preemptive Rights Holder’s Pro Rata Portion of the Target Shares (the “Purchasing Holders”). Such Overallotment Notice may be made by telephone if confirmed in
writing within two (2) days. The Purchasing Holders shall have a right of overallotment such that they shall have five (5) days from the date such Overallotment Notice was given to agree to buy their Overallotment Pro Rata Portion of the
unsold portion of the Target Shares. The term “Overallotment Pro Rata Portion” shall mean that number of shares of Common Stock equal to the product obtained by multiplying (i) the aggregate number of Target Shares not already
purchased by the Company and the Preemptive Rights Holders by (ii) a fraction, the numerator of which is the number of shares of capital stock of the Company owned by the Purchasing Holder and the denominator of which is the total number of
shares of capital stock of the Company owned by all Purchasing Holders at the time of the Notice. 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 19 

 (d) Co-Sale Right. In the event that (i) the Company either waived or failed to
fully exercise its first refusal right contained in Section 4.1(b) with respect to any Target Shares and (ii) the Preemptive Rights Holders failed to purchase all any of the Target Shares pursuant to the Secondary Refusal Right, then such
Selling Founder promptly shall give written notice (the “Co-Sale Notice”) to the Company and the Preemptive Rights Holders at least ten (10) days following the expiration of the Secondary Refusal Right. Each Preemptive Rights
Holder shall have the right, exercisable for thirty (30) days after the date of the Co-Sale Notice, to sell to the proposed transferee of such Target Shares up to such Preemptive Rights Holder’s Co-Sale Pro Rata Share (as defined below) of
the Target Shares that the Selling Founder proposes to sell, on the same terms and conditions as those set forth in the Notice. To the extent that one or more of the Preemptive Rights Holders exercise such right of participation in accordance with
the terms and conditions set forth below, the number of shares of Common Stock that the Selling Founder may sell in the transaction shall correspondingly be reduced. 
 (e) Special Definitions. For purposes of this Section 4, “Co-Sale Pro Rata Share” shall mean that number of shares of Common Stock equal to the product obtained by multiplying
(i) the aggregate number of Target Shares covered by the Co-Sale Notice by (ii) a fraction, the numerator of which shall be the total number of shares of capital stock of the Company held by such Preemptive Rights Holder on a “fully
diluted” basis as of the date of the Co-Sale Notice, and the denominator of which shall be the total number of shares of Common Stock held by the Selling Founder and the Preemptive Rights Holders on a “fully diluted” basis
outstanding as of the date of the Co-Sale Notice. The term “fully-diluted” shall mean the number of shares of Common Stock that would be held if all currently outstanding options, warrants and rights to purchase or convert other securities
into Common Stock were exercised in full. 
 4.2 Effect of Nonparticipation. Subject to the rights of Preemptive Rights
Holders under Section 4.1, the Selling Founder may, within 60 days after the expiration of the 30-day period referred to in Section 4.1(d) above, conclude a sale of any or all of its shares covered by the Co-Sale Notice on terms and
conditions not more favorable to the transferor than those described in the Co-Sale Notice. Any proposed sale on terms and conditions more favorable to the transferor than those described in the Notice, as well as any proposed sale by the Selling
Founder of any Shares after the expiration of such 60-day period, shall again be subject to this Section 4. 
 4.3
Exempt Transfers. 
 (a) Notwithstanding the foregoing, the provisions of Section 4.1 shall not apply to: (i) any
pledge of Common Stock made pursuant to a bona fide loan transaction that creates a mere security interest to which the holders of a majority of the Series E Stock then outstanding shall have consented; (ii) any transfer to the spouse,
lineal descendants or antecedents, parents, siblings, or to trusts for the benefit of such persons or the Founder, whether such transfer occurs during the Founder’s lifetime or on the Founder’s death by will or intestacy; or (iii) any
bona fide gift; provided that the pledgee, transferee or donee shall furnish the Preemptive Rights Holders with a written agreement to be bound by and comply with all provisions of this Agreement. Such transferred Common Stock shall remain
“Common Stock” under this Agreement, and such pledgee, transferee or donee shall be treated as a Founder for purposes of this Agreement, provided that no such pledgee, transferee or donee shall have any registration rights under
Section 1 of

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 20 

 
this agreement. Any transfers of Common Stock to the Company upon exercise of the right of repurchase or right of first refusal set forth in any founders’ stock purchase agreement, option
exercise agreement or other agreement with the Company that was entered into by the Founder at the time he or she acquired such Common Stock shall also be exempt from the provisions of Section 4.1. 
 (b) Without limiting the foregoing, the provisions of Section 4.1 shall not apply to the sale of any Common Stock by a Founder, in one
sale or several sales, related or unrelated, of up to 3% in the aggregate of the number of shares of Common Stock held by such Founder as of the date of this Agreement. 
 4.4 Termination of Rights of First Refusal and Co-Sale Rights. The rights and obligations of the parties under this Section 4 shall terminate upon and shall not apply to a Qualified IPO; or
(b) the closing of the Company’s sale of all or substantially all of its assets, or the acquisition of the Company by another unaffiliated entity by means of a merger or consolidation resulting in the exchange of the outstanding shares of
the Company’s capital stock for publicly traded securities or cash consideration issued, or caused to be issued, by the acquiring entity or its subsidiary. 
 Section 5. ADDITIONAL COVENANTS 
 5.1 Stock Vesting. Unless otherwise
unanimously approved by the Board, all stock options and other stock equivalents issued after the date of this Agreement to employees, directors, consultants and other service providers shall be subject to vesting as follows: (a) twenty-five
percent (25%) of such stock shall vest at the end of the first year following the earlier of the date of issuance or such person’s services commencement date with the company, and (b) seventy-five percent (75%) of such stock
shall vest over the remaining three (3) years. With respect to any shares purchased by any such person, the Company’s repurchase option shall provide that upon such person’s termination of employment or service with the Company, with
or without cause, the Company or its assignee shall have the option to purchase at cost any unvested shares of stock held by such person. 
 5.2 Right of First Refusal and Restrictions on Transfer on Common Stock. All shares of Common Stock of the Company will, at all times, be subject to a right of first refusal in favor of the Company
and restrictions against transfer. The Company shall assign any such rights of first refusal that it chooses not to exercise to the holders of Preferred Stock on a pro rata basis. 
 5.3 Proprietary Information and Inventions Agreements. The Company shall require all employees and consultants to execute and deliver
a Proprietary Information and Inventions Agreement substantially in a form approved by the Company’s counsel or Board. 
 5.4 Qualified Small Business. The Company will use reasonable efforts to comply with the reporting and recordkeeping requirements of Section 1202 of the Internal Revenue Code of 1986, as amended (the “Code”),
any regulations promulgated thereunder and any similar state laws and regulations, and agrees not to repurchase any stock of the Company if such repurchase 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 21 

 
would cause the Shares not to so qualify as “Qualified Small Business Stock,” so long as the Company’s Board of Directors determines that it is in the best interests of and
not unduly burdensome to the Company to comply with the provisions of Section 1202 of the Code. The Company further covenants to submit to the Investors upon their request and to state and federal taxation authorities such form and filings as
may be required to document such compliance, including the California Franchise Tax Board Form 3565, Small Business Stock Questionnaire, with its franchise or income tax return for the current income year. 
 5.5 Market Stand-Off. The Company will include or has included a market-standoff provision similar to Section 1.10 in all
employee stock purchase agreements and other registration rights agreements. 
 5.6 Directors and Officers Liability
Insurance. The Company will use its best efforts to obtain and keep directors and officers liability insurance in the minimum amount of $2,000,000 if such coverage is available at commercially reasonable rates. Such coverage will be kept in
place for so long as any representative(s) of Menlo Ventures or its Affiliates serve on the Company’s Board of Directors. 
 5.7 Termination of Covenants. All covenants of the Company contained in Section 5.1, 5.2, 5.3 and 5.4 shall expire and terminate as to each Investor upon the earlier to occur of (a) a Qualified IPO; or (b) the closing
of the Company’s sale of all or substantially all of its assets, or the acquisition of the Company by another unaffiliated entity by means of a merger or consolidation resulting in the exchange of the outstanding shares of the Company’s
capital stock for publicly traded securities or cash consideration issued, or caused to be issued, by the acquiring entity or its subsidiary. 
 Section 6. MISCELLANEOUS 
 6.1 Governing Law. This Agreement shall be governed in all respects by the
laws of the State of California as such laws are applied to agreements between California residents entered into and to be performed entirely within California. 
 6.2 Survival. The covenants and agreements made herein shall survive any investigation made by any party hereto and the closing of the transactions contemplated hereby. 
 6.3 Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof will inure to the benefit of, and be
binding upon the successors, assigns, heirs, transferees, executors and administrators of the parties hereto. 
 6.4 Entire
Agreement; Amendment and Waiver. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subjects hereof. This Agreement may be amended or waived only by a writing approved by
(i) the Company, (ii) the holders of a majority of the shares of Series E Stock and shares of Common Stock issuable upon conversion of the Series E Stock held by the holders of Series E Stock, and (iii) the holders of a majority of
the shares of Preferred Stock and 
  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 22 

 
shares of Common Stock issuable upon conversion of the Preferred Stock held by the Preferred Holders; and provided further, that (i) no amendment may be made that adversely affects the
rights of the Founders in a manner that is materially and adversely different from the manner in which the rights of the holders of common stock are so effected without the written consent of the Founders holding a majority of the Founders Stock
then held by the Founders and (ii) no future registration rights may be granted by the Company other than in compliance with Section 1.9 hereof. 
 6.5 Notices. Except as otherwise provided, all notices and other communications required or permitted hereunder will be in writing and will be given by telegram, telecopy or other facsimile
transmission, express courier holding itself out as able to make delivery within one business day after receipt, hand delivery, or certified or first class mail, postage prepaid, addressed (a) if to Preferred Holders, at each Preferred
Holder’s address or facsimile transmission number set forth on Exhibit A attached hereto, or at such other address or facsimile transmission number as Preferred Holders will have furnished to the Company in writing, or (b) if
to any other Holder of any of the Registrable Securities, at such address or facsimile transmission number as such Holder will have furnished the Company in writing, or, until any such Holder so furnishes an address and facsimile transmission number
to the Company, then to and at the address or facsimile transmission number of the last Holder of such securities who has so furnished an address to the Company, (c) if to the Company, at its address set forth on the signature page hereto, or
at such other address or facsimile transmission number as the Company will have furnished to the Preferred Holders in writing, or (d) if to a Founder, at such Founder’s address or facsimile transmission number set forth on
Exhibit B attached hereto, or at such other address or facsimile transmission number as such Founder will have furnished to the Company in writing. Notice will be effective one business day after delivery to an express courier, or upon
receipt if: (i) hand delivered; (ii) deposited in the United States mail as provided above; or (iii) sent by facsimile transmission (with return confirmation). 
 6.6 Title and Subtitles. The titles of the paragraphs and subparagraphs of this Agreement are for convenience of reference only and
are not to be considered in construing this Agreement. 
 6.7 Counterparts. This Agreement may be executed in any number
of counterparts, each of which will be an original, but all of which together will constitute one instrument. 
 6.8
Severability. In case any provision of this Agreement shall be invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby.

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 23 

 6.9 Preservation of Corporate Existence. The Company covenants and agrees that it
will at all times (i) preserve and maintain its corporate existence, rights, franchises and privileges in the jurisdiction of its incorporation, and qualify and remain qualified as a foreign corporation in each jurisdiction in which such
qualification is necessary or desirable in view of its business and operations or the ownership or lease of its properties, and (ii) preserve and maintain all licenses and other rights to use Intellectual Property owned or possessed by it and
deemed by the Company to be necessary or useful to the conduct of its business. 
 6.10 Aggregation of Stock. All shares
of capital stock of the Company held or acquired by an Affiliate shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 
 6.11 Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party, upon
any breach, default or noncompliance by another party under this Agreement shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of or in
any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on any party’s part of any breach, default or noncompliance under this Agreement or
any waiver on such party’s part of any provisions or conditions of the Agreement must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement by law, or otherwise
afforded to any party, shall be cumulative and not alternative. 
 [Remainder of page left intentionally blank.]

  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 24 

 IN WITNESS WHEREOF, this Fifth Amended and Restated Investors’ Rights Agreement
shall become effective as of the Effective Date upon the Company’s receipt of the requisite signatures set forth in Section 6.4 of the existing Fourth Amended and Restated Investors’ Rights Agreement dated as of the January 26,
2006. 
  

							
	COMPANY:	 		 		 	TELENAV, INC.
				
		 		 		 	 /s/ Dr. HaiPing Jin

		 		 		 	Dr. HaiPing Jin
		 		 		 	President and Chief Executive Officer

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 FOUNDERS: 
  

	
	 /s/ Dr. HaiPing Jin

	Dr. HaiPing Jin
	
	 /s/ Yi-Chung Chao

	Yi-Chung Chao
	
	 /s/ Robert Rennard

	Robert Rennard
	
	 /s/ Charles Trimble

	Charles Trimble*
	
	 /s/ Jeannie Trimble Smith

	Jeannie Trimble Smith*
	
	 /s/ Kari Trimble Patrick

	Kari Trimble Patrick*
	
	 /s/ Constance Trimble Morrison

	Constance Trimble Morrison*
	
	 /s/ Thomas Rennard

	Thomas Rennard*
	
	 /s/ Kristin Rennard

	Kristin Rennard*

  

	*	This stockholder is a transferee of either HaiPing Jin, Robert Rennard or Yi-Chung Chao and is treated as a Founder for the purposes of this Agreement.

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 FOUNDERS: 
  

			
	ROBERT RENNARD AND SHERRY RENNARD, AS COMMUNITY PROPERTY*
		
	By:	 	 /s/ Robert Rennard

	Robert Rennard
		
	By:	 	 /s/ Sherry Rennard

	Sherry Rennard*
	
	  

	Cunlian Zhang*
	
	  

	Rantai Wang*
	
	  

	Scott Taek Kon Kim*
	
	  

	Je Hye Kim*
	
	  

	Jiansong Piao*
	
	  

	Jianbai Piao*
	
	  

	Wenjie Xu*
	
	  

	Ling Wang*

  

	*	This stockholder is a transferee of either HaiPing Jin, Robert Rennard or Yi-Chung Chao and is treated as a Founder for the purposes of this Agreement.

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 FOUNDERS: 
  

	
	  

	Muhua Shi*
	
	  

	Dan Wang*
	
	  

	Hong Li*
	
	  

	Changbin Wang*
	
	  

	Guangshou Jin*
	
	  

	Jidong Jin*
	
	  

	Haiyang Jin*
	
	  

	Jacqueline Jin*
	
	  

	Michael Jin*

  

	*	This stockholder is a transferee of either HaiPing Jin, Robert Rennard or Yi-Chung Chao and is treated as a Founder for the purposes of this Agreement.

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	MENLO VENTURES X, L.P.
	MENLO ENTREPRENEURS FUND X, L.P.
	MMEF X, L.P.
		
	By:	 	MV Management X, L.L.C.
		 	their General Partner
		
	By:	 	 /s/ Shawn Carolan

	Name:	 	 Shawn Carolan

	Its:	 	 Managing Member

	
	TENAYA CAPITAL IV-C, LP (formerly known as Lehman Brothers Venture Partners 2003-C, L.P.)
		
	By:	 	Tenaya Capital IV GP, LP
		 	its General Partner
		
	By:	 	Tenaya Capital IV GP, LLC
		 	its General Partner
		
	By:	 	 /s/ James D. Hinson

	Name:	 	 James D. Hinson

	Its:	 	 COO

	
	TENAYA CAPITAL IV-P, LP (formerly known as Lehman Brothers Venture Partners 2003-P, L.P.)
		
	By:	 	Tenaya Capital IV GP, LP
		 	its General Partner
		
	By:	 	Tenaya Capital IV GP, LLC
		 	its General Partner
		
	By:	 	 /s/ James D. Hinson

	Name:	 	 James D. Hinson

	Its:	 	 COO

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	LEHMAN BROTHERS VENTURE CAPITAL 2003 PARTNERSHIP
		
	By:	 	Lehman Brothers Venture Associates 2003 LLC
		 	its General Partner
		
	By:	 	LB I Group Inc.
		 	its General Partner
		
	By:	 	  

	Name:	 	 Brian Paul

	Its:	 	 Vice President

	
	LEHMAN BROTHERS P.A. LLC
		
	By:	 	  

	Name:	 	 Brian Paul

	Its:	 	 Vice President

	
	LEHMAN BROTHERS VENTURE CAPITAL PARTNERS II, L.P.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	LEHMAN BROTHERS PARTNERSHIP ACCOUNT 2000/2001, L.P.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	 LEHMAN BROTHERS OFFSHORE
 PARTNERSHIP ACCOUNT 2000/2001, L.P.

		
	 By:
	 	  

	 Name:
	 	  

	 Its:
	 	  

	
	 /s/ Samuel T. Chen

	Samuel T. Chen
	
	IGLOBE PARTNERS FUND, L.P.
		
	 By:
	 	 /s/ Soo Boon Koh

	 Name:
	 	 Soo Boon Koh

	 Its:
	 	 Managing Partner

	
	 /s/ Hon Jane Chiu

	Hon Jane Chiu
	
	 /s/ Hang-Chien Hsu

	Hang-Chien Hsu
	
	SYCAMORE VENTURE CAPITAL, L.P.
		
	 By:
	 	Sycamore Business Partners, L.P.
		 	its General Partner
		
	 By:
	 	Sycamore Management Corporation
		 	its General Partner
		
	 By:
	 	 /s/ David Lichtenstein

	 Name:
	 	 David Lichtenstein

	 Its:
	 	 Vice President

	
	  

	Shih-Chia Pao

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	CG ASIAN-AMERICAN FUND, L.P.
		
	By:	 	CG Asian-American Partners, L.P.
		 	its General Partner
		
	 By:
	 	Sycamore Management Corporation
		 	its General Partner
		
	 By:
	 	 /s/ David Lichtenstein

	 Name:
	 	 David Lichtenstein

	 Its:
	 	 Vice President

	
	 /s/ Stephen Sun Chiao

	Stephen Sun Chiao
	
	  
 Shan-Shan Fang

	
	 /s/ Dr. HaiPing Jin

	Dr. HaiPing Jin
	
	 /s/ Yi-Chung Chao

	Yi-Chung Chao
	
	  
 Robert Rennard

	
	 /s/ Xiaogang Zhang

	Xiaogang Zhang
	
	 /s/ Xun Chen

	Xun Chen

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	XIE FAMILY TRUST, DATED 7/29/99
		
	By:	 	 /s/ Ken Xie

	Name:	 	 Ken Xie

	Its:	 	 Trustee

	
	NAVIGO CAPITAL GROUP, L.P.
		
	By:	 	NCG Holdings, LLC
		 	its General Partner
		
	By:	 	 /s/ Michael Probstel

	Name:	 	 Michael Probstel

	Its:	 	 Manager

	
	 /s/ Stephen Sun Chiao, attorney in fact

	John R. Whitman
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Kit C. Wong
	
	 /s/ J. David Powell

	J. David Powell
	
	  
 Steven Sun

	
	 /s/ Max G. Lagally

	Max G. Lagally
	
	  
 Ken Hao

	
	  
 Su Chien-Ling
Chen

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

	
	
	  
 Tejen Lin

	
	  
 Shu-Yuan Chao

	
	  
 Darsen Horng

	
	 /s/ Todd Bakar

	Todd Bakar
	
	  
 Soot Pheng Yim

	
	 /s/ Michael Xie

	Michael Xie
	
	  
 Lian S. Xie

	
	 /s/ Yuqiang Qin

	Yuqiang Qin
	
	 /s/ Zhenshu Zhao

	Zhenshu Zhao
	
	  
 Lei Wang

	
	 /s/ Hongjian Liu

	Hongjian Liu

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	TECHNOLOGY LINK CAPITAL
		
	By:	 	 /s/ Lee-Hwa Pearlshine

	Name:	 	 Lee-Hwa Pearlshine

	Its:	 	 Director

	
	 1998 WANG/CHANG FAMILY REVOCABLE
 TRUST

		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	GRADE INVESTMENT CORP.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	TU REVOCABLE TRUST, DATED 2/14/90
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	XI JIN AND ANDREW JI
		
	By:	 	  

	By:	 	  

	
	  
 Lynn Liu

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

	
	
	  
 Alnoor
Shivji

	
	  
 Sami Nassar

	
	 /s/ Nusrat N. Govindji

	Nusrat N. Govindji
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Kilin To
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Richard Chong
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Subir Ray
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Michael Horgan
	
	 /s/ Stephen Sun Chiao, attorney in fact

	William W. Morton, Jr.
	
	 /s/ Kamal K. Mirchandani

	Kamal K. Mirchandani
	
	 /s/ Simon Wong

	Simon Wong
	
	 /s/ Stephen Sun Chiao, attorney in fact

	Peter Gerry

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	BINGHAM MCCUTCHEN LLP
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	EVERTOP INTERNATIONAL LIMITED (BVI)
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	ARIES MANAGEMENT GROUP, INC.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	 /s/ Fiona Chang

	Fiona Chang
	
	THE WU FAMILY TRUST DATED 3/17/92
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	CLASS-A INVESTMENTS LTD.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	AVEX INVESTMENT HOLDINGS LIMITED
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	SPRINGVEST CORPORATION
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	THE LIN FAMILY 1987 TRUST
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	 /s/ Shyan-Hwant Chen

	Shyan-Hwang Chen
	
	CYBER PLUS LTD.
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	  
 Chan-Yee Hsiung

	
	  
 Chi-Mao Huang

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 PREFERRED HOLDERS: 
  

			
	
	  
 Chin-Feng
Lin

	
	  
 Chih-Cheng Liu

	
	NEW RAINBOW INVESTMENT LIMITED
		
	By:	 	  

	Name:	 	  

	Its:	 	  

	
	  
 Chien-Tung Chen

	
	CHI-PING CHEN AND FENG-YUAN L. CHEN
		
	By: 	 	 /s/ Chi-Ping Chen

		
	By: 	 	 /s/ Feng-Yuan L. Chen

	
	  
 Fu-Shun Ko

	
	  
 Zu-Jean Tien

	
	  
 Cheng-Hsien Wu

	
	  
 Hsiung Wu

	
	  
 Andy Wan Yu

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 SIGNATURE PAGE 

 EXHIBIT A 
 Preferred Holders 
  

	
	Series A Holders
	
	 Technology Link Capital

	
	 Evertop International Limited (BVI)

	
	 Xiaogang Zhang

	
	 Xie Family Trust, dated 7/29/99

	
	 Su Chien-Ling Chen

	
	 Darsen Horng

	
	 Max G. Lagally

	
	 Tu Revocable Trust, dated 2/14/90

	
	 1998 Wang/Chang Family Revocable Trust

	
	 Xun Chen

	
	 Michael Xie

	
	 Shu-Yuan Chao

	
	 Grade Investment Corp.

	
	 Tejen Lin

	
	 Todd Bakar

	
	 J. David Powell

	
	 Bingham McCutchen LLP

	
	 Soot Pheng Yim

	
	 Steven Sun

	
	 Dr. HaiPing Jin

	
	 Ken Hao

	
	 Robert Rennard

	
	 Xi Jin and Andrew Ji

	
	 Yi-Chung Chao

	
	 Lian S. Xie

	
	 Yuqiang Qin

	
	 Zhenshu Zhao

	
	 Lei Wang

	
	 Hongjian Liu

 TELENAV, INC. 
 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT A-1 

	
	Series B Holders
	
	 Sycamore Venture Capital, L.P.

	
	 Technology Link Capital

	
	 CG Asian-American Fund, L.P.

	
	 Evertop International Limited (BVI)

	
	 The Lin Family 1987 Trust

	
	 Darsen Horng

	
	 Aries Management Group, Inc.

	
	 Alnoor Shivji

	
	 Su Chien-Ling Chen

	
	 Kamal K. Mirchandani

	
	 Nusrat N. Govindji

	
	 Sami Nassar

	
	 The Wu Family Trust dated 3/17/92

	
	 Kilin To

	
	 Michael Horgan

	
	 Peter Gerry

	
	 Richard Chong

	
	 Simon Wong

	
	 Subir Ray

	
	 William W. Morton, Jr.

	
	 Lynn Liu

	
	 Class-A Investments Ltd.

	
	 Avex Investment Holdings Limited

	
	 Springvest Corporation

 TELENAV, INC. 
 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT A-2 

	
	Series B Prime Holders
	
	 iGlobe Partners Fund, LP

	
	 Navigo Capital Group, L.P.

	
	 Kit C. Wong

	
	 John R. Whitman

	
	Series C Holders
	
	 Sycamore Venture Capital, L.P.

	
	 CG Asian-American Fund, L.P.

	
	 Kit C. Wong

	
	 Kilin To

	
	 Simon Wong

	
	 John R. Whitman

	
	 Peter Gerry

	
	 Richard Chong

	
	 Subir Ray

	
	 Michael Horgan

	
	 William W. Morton, Jr.

	
	 Hon Jane Chiu

	
	 Hang-Chien Hsu

	
	 iGlobe Partners Fund, LP

 TELENAV, INC. 
 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT A-3 

	
	Series C Prime Holders
	 Samuel T. Chen

	
	 Hon Jane Chiu

	
	 Hang-Chien Hsu

	
	 Kit C. Wong

	
	 John R. Whitman

	
	 Navigo Capital Group, L.P.

	
	 iGlobe Partners Fund, LP

  

	
	Series D Holders
	 Fiona Chang

	
	 Samuel T. Chen

	
	 Bingham McCutchen LLP

 TELENAV, INC. 
 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT A-4 

	
	Series E Holders
	
	 Menlo Ventures X, L.P.

	
	 Menlo Entrepreneurs Fund X, L.P.

	
	 MMEF X, L.P.

	
	 Tenaya Capital IV-C, LP

	
	 Tenaya Capital IV-P, LP

	
	 Lehman Brothers Venture Capital 2003 Partnership

	
	 Lehman Brothers P.A. LLC

	
	 Lehman Brothers Venture Capital Partners II, L.P.

	
	 Lehman Brothers Partnership Account 2000/2001, L.P.

	
	 Lehman Brothers Offshore Partnership Account 2000/2001, L.P.

	
	 Hon Jane Chiu

	
	 Hang-Chien Hsu

	
	 iGlobe Partners Fund, LP

	
	 Sycamore Venture Capital, L.P.

	
	 CG Asian-American Fund, L.P.

	
	 Stephen Sun Chiao

	
	 Shan-Shan Fang

	
	 Fiona Chang

	
	 Shyan-Hwang Chen

	
	 Shih-Chia Pao

	
	 Cyber Plus Ltd.

	
	 Chan-Yee Hsiung

	
	 Chi-Mao Huang

	
	 Chi-Feng Lin

	
	 Chih-Cheng Liu

	
	 New Rainbow Investment Limited

	
	 Chien-Tung Chen

	
	 Chi-Ping Chen and Feng-Yuan L. Chen

	
	 Fu-Shun Ko

	
	 Zu-Jean Tien

	
	 Cheng-Hsien Wu

	
	 Hsiung Wu

	
	 Andy Wan Yu

 TELENAV, INC. 
 FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT A-5 

 EXHIBIT B 
 Founders 
  

	
	Holder
	
	 Dr. HaiPing Jin

	
	 Yi-Chung Chao

	
	 Robert Rennard

	
	 Charles Trimble*

	
	 Jeannie Trimble Smith*

	
	 Kari Trimble Patrick*

	
	 Constance Trimble Morrison*

	
	 Thomas Rennard*

	
	 Kristin Rennard*

	
	 Robert Rennard and Sherry Rennard, as Community Property*

	
	 Cunlian Zhang*

	
	 Rantai Wang*

	
	 Scott Taek Kon Kim*

	
	 Je Hye Kim*

	
	 Jiansong Piao*

	
	 Jianbai Piao*

	
	 Wenjie Xu*

	
	 Ling Wang*

	
	 Muhua Shi*

  

	*	This stockholder is a transferee of either HaiPing Jin, Robert Rennard or Yi-Chung Chao and is treated as a Founder for the purposes of this Agreement.

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT B-1 

	
	 Dan Wang*

	
	 Hong Li*

	
	 Changbin Wang*

	
	 Guangshou Jin*

	
	 Jidong Jin*

	
	 Haiyang Jin*

	
	 Jacqueline Jin*

	
	 Michael Jin*

  

	*	This stockholder is a transferee of either HaiPing Jin, Robert Rennard or Yi-Chung Chao and is treated as a Founder for the purposes of this Agreement.

 TELENAV, INC. 
 FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS
AGREEMENT 
 EXHIBIT B-2Form of Indemnification Agreement

 Exhibit 10.1 
 TELENAV, INC. 
 INDEMNIFICATION AGREEMENT

 This Indemnification Agreement (this “Agreement”) is dated as of
            , 20    , and is between TeleNav, Inc., a Delaware corporation (the “Company”), and
                             (“Indemnitee”). 
 RECITALS 
 A. Indemnitee’s service to the Company substantially benefits the Company. 
 B. Individuals are reluctant to
serve as directors or officers of corporations or in certain other capacities unless they are provided with adequate protection through insurance or indemnification against the risks of claims and actions against them arising out of such service.

 C. Indemnitee does not regard the protection currently provided by applicable law, the Company’s governing documents and
any insurance as adequate under the present circumstances, and Indemnitee may not be willing to serve as a director or officer without additional protection. 
 D. In order to induce Indemnitee to continue to provide services to the Company, it is reasonable, prudent and necessary for the Company to contractually obligate itself to indemnify, and to advance
expenses on behalf of, Indemnitee as permitted by applicable law. 
 E. This Agreement is a supplement to and in furtherance of
the indemnification provided in the Company’s certificate of incorporation and bylaws, and any resolutions adopted pursuant thereto, and this Agreement shall not be deemed a substitute therefor, nor shall this Agreement be deemed to limit,
diminish or abrogate any rights of Indemnitee thereunder. 
 The parties therefore agree as follows: 
 1. Definitions. 
 (a) A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events: 
 (i) Acquisition of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing
fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities; 
 (ii)
Change in Board Composition. During any period of two consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Company’s board of directors, and
any new directors (other than a director designated by a person who has entered into an agreement with the Company to effect a

 
transaction described in Sections 1(a)(i), 1(a)(iii) or 1(a)(iv)) whose election by the board of directors or nomination for election by the Company’s stockholders was approved by a vote of
at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the
members of the Company’s board of directors; 
 (iii) Corporate Transactions. The effective date of a merger or
consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by
remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and
with the power to elect at least a majority of the board of directors or other governing body of such surviving entity; 
 (iv)
Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets; and 
 (v) Other Events. Any other event of a nature that would be required to be reported in response to Item 6(e) of
Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange Act of 1934, as amended, whether or not the Company is then subject to such reporting
requirement. 
 For purposes of this Section 1(a), the following terms shall have the following meanings: 
 (1) “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934,
as amended; provided, however, that “Person” shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any corporation
owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. 
 (2) “Beneficial Owner” shall have the meaning given to such term in Rule 13d-3 under the Securities Exchange Act of 1934, as amended; provided, however, that
“Beneficial Owner” shall exclude any Person otherwise becoming a Beneficial Owner by reason of (i) the stockholders of the Company approving a merger of the Company with another entity or (ii) the Company’s board of
directors approving a sale of securities by the Company to such Person. 
 (b) “Corporate Status” describes the
status of a person who is or was a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of the Company or any other Enterprise. 
 (c) “DGCL” means the General Corporation Law of the State of Delaware. 
  

 -2- 

 (d) “Disinterested Director” means a director of the Company who is not and
was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. 
 (e)
“Enterprise” means the Company and any other corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as
a director, trustee, general partner, managing member, officer, employee, agent or fiduciary. 
 (f) “Expenses”
include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees and costs of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and
all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding.
Expenses also include (i) Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond or other appeal bond or
their equivalent, and (ii) for purposes of Section 12(c), Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement or under any directors’ and
officers’ liability insurance policies maintained by the Company. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. 
 (g) “Independent Counsel” means a law firm, or a partner or member of a law firm, that is experienced in matters of
corporation law and neither presently is, nor in the past five years has been, retained to represent (i) the Company or Indemnitee in any matter material to either such party (other than as Independent Counsel with respect to matters concerning
Indemnitee under this Agreement, or other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term
“Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to
determine Indemnitee’s rights under this Agreement. 
 (h) “Proceeding” means any threatened, pending or
completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal,
administrative or investigative nature, including any appeal therefrom and including without limitation any such Proceeding pending as of the date of this Agreement, in which Indemnitee was, is or will be involved as a party, a potential party, a
non-party witness or otherwise by reason of (i) the fact that Indemnitee is or was a director or officer of the Company, (ii) any action taken by Indemnitee or any action or inaction on Indemnitee’s part while acting as a director or
officer of the Company, or (iii) the fact that he or she is or was serving at the request of the Company as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of the Company or any other Enterprise, in
each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification or advancement of expenses can be provided under this Agreement. 
  

 -3- 

 (i) Reference to “other enterprises” shall include employee benefit plans;
references to “fines” shall include any excise taxes assessed on a person with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as a director,
officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith
and in a manner he or she reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Company”
as referred to in this Agreement. 
 2. Indemnity in Third-Party Proceedings. The Company shall indemnify Indemnitee in
accordance with the provisions of this Section 2 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor.
Pursuant to this Section 2, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her
behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any
criminal action or proceeding, had no reasonable cause to believe that his or her conduct was unlawful. 
 3. Indemnity in
Proceedings by or in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in
the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on
Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company. No
indemnification for Expenses shall be made under this Section 3 in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the
extent that the Delaware Court of Chancery or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and
reasonably entitled to indemnification for such expenses as the Delaware Court of Chancery or such other court shall deem proper. 
 4. Indemnification for Expenses of a Party Who is Wholly or Partly Successful. To the extent that Indemnitee is a party to or a participant in and is successful (on the merits or otherwise) in defense of any Proceeding or any claim,
issue or matter therein, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. To the extent permitted by applicable law, if Indemnitee is
not wholly successful in such Proceeding but is successful, on the merits or otherwise, in defense of one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually
and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with (a) each successfully resolved claim, issue or matter and (b) any claim, issue or matter related to any such successfully resolved claim, issue or
matter. For purposes of this section, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 
  

 -4- 

 5. Indemnification for Expenses of a Witness. To the extent that Indemnitee is, by
reason of his or her Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified to the extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or
on Indemnitee’s behalf in connection therewith. 
 6. Additional Indemnification. 
 (a) Notwithstanding any limitation in Sections 2, 3 or 4, the Company shall indemnify Indemnitee to the fullest extent permitted by
applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and
amounts paid in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection with the Proceeding or any claim, issue or matter therein. 
 (b) For purposes of Section 6(a), the meaning of the phrase “to the fullest extent permitted by applicable law” shall include, but not be limited to: 
 (i) the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or
the corresponding provision of any amendment to or replacement of the DGCL; and 
 (ii) the fullest extent authorized or
permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. 
 7. Exclusions. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any
indemnity in connection with any Proceeding (or any part of any Proceeding): 
 (a) for which payment has actually been made to
or on behalf of Indemnitee under any statute, insurance policy, indemnity provision, vote or otherwise, except with respect to any excess beyond the amount paid; 
 (b) for an accounting or disgorgement of profits pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, or similar provisions of federal, state or local statutory law or common
law, if Indemnitee is held liable therefor (including pursuant to any settlement arrangements); 
 (c) for any reimbursement of
the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Securities Exchange Act of 1934, as
amended (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits
arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act), if Indemnitee is held liable therefor (including pursuant to any settlement arrangements); 
  

 -5- 

 (d) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding)
initiated by Indemnitee against the Company or its directors, officers, employees, agents or other indemnitees, unless (i) the Company’s board of directors authorized the Proceeding (or the relevant part of the Proceeding) prior to its
initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, (iii) otherwise authorized in Section 12(c) or (iv) otherwise required by
applicable law; or 
 (e) if prohibited by applicable law. 
 8. Advances of Expenses. The Company shall advance the Expenses incurred by Indemnitee in connection with any Proceeding, and such
advancement shall be made as soon as reasonably practicable, but in any event no later than 30 days, after the receipt by the Company of a written statement or statements requesting such advances from time to time (which shall include invoices
received by Indemnitee in connection with such Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditure made that would cause Indemnitee to waive any privilege accorded by
applicable law shall not be included with the invoice). Advances shall be unsecured and interest free and made without regard to Indemnitee’s ability to repay such advances. Indemnitee hereby undertakes to repay any advance to the extent that
it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company. This Section 8 shall not apply to the extent advancement is prohibited by law and shall not apply to any Proceeding for which indemnity is not
permitted under this Agreement, but shall apply to any Proceeding referenced in Section 7(b) or 7(c) prior to a determination that Indemnitee is not entitled to be indemnified by the Company. 
 9. Procedures for Notification and Defense of Claim. 
 (a) Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses as soon as reasonably practicable following the
receipt by Indemnitee of notice thereof. The written notification to the Company shall include, in reasonable detail, a description of the nature of the Proceeding and the facts underlying the Proceeding. The failure by Indemnitee to notify the
Company will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying the Company shall not constitute a waiver by Indemnitee of any rights, except to
the extent that such failure or delay materially prejudices the Company. 
 (b) If, at the time of the receipt of a notice of a
Proceeding pursuant to the terms hereof, the Company has directors’ and officers’ liability insurance in effect, the Company shall give prompt notice of the commencement of the Proceeding to the insurers in accordance with the procedures
set forth in the applicable policies. The Company shall thereafter take all commercially-reasonable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of
such policies. 
  

 -6- 

 (c) In the event the Company may be obligated to make any indemnity in connection with a
Proceeding, the Company shall be entitled to assume the defense of such Proceeding with counsel approved by Indemnitee, which approval shall not be unreasonably withheld, upon the delivery to Indemnitee of written notice of its election to do so.
After delivery of such notice, approval of such counsel by Indemnitee and the retention of such counsel by the Company, the Company will not be liable to Indemnitee for any fees or expenses of counsel subsequently incurred by Indemnitee with respect
to the same Proceeding. Notwithstanding the Company’s assumption of the defense of any such Proceeding, the Company shall be obligated to pay the fees and expenses of Indemnitee’s counsel to the extent (i) the employment of counsel by
Indemnitee is authorized by the Company, (ii) counsel for the Company or Indemnitee shall have reasonably concluded that there is a conflict of interest between the Company and Indemnitee in the conduct of any such defense such that Indemnitee
needs to be separately represented, (iii) the Company is not financially or legally able to perform its indemnification obligations or (iv) the Company shall not have retained, or shall not continue to retain, such counsel to defend such
Proceeding. The Company shall have the right to conduct such defense as it sees fit in its sole discretion. Regardless of any provision in this Agreement, Indemnitee shall have the right to employ counsel in any Proceeding at Indemnitee’s
personal expense. The Company shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Company. 
 (d) Indemnitee shall give the Company such information and cooperation in connection with the Proceeding as may be reasonably appropriate. 
 (e) The Company shall not be liable to indemnify Indemnitee for any settlement of any Proceeding (or any part thereof) without the
Company’s prior written consent, which shall not be unreasonably withheld. 
 (f) The Company shall have the right to
settle any Proceeding (or any part thereof) without the consent of Indemnitee. 
 10. Procedures upon Application for
Indemnification. 
 (a) To obtain indemnification, Indemnitee shall submit to the Company a written request, including
therein or therewith such documentation and information as is reasonably available to Indemnitee and as is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of the
Proceeding. The Company shall, as soon as reasonably practicable after receipt of such a request for indemnification, advise the board of directors that Indemnitee has requested indemnification. Any delay in providing the request will not relieve
the Company from its obligations under this Agreement, except to the extent such failure is prejudicial. 
 (b) Upon written
request by Indemnitee for indemnification pursuant to Section 10(a), a determination, if required by applicable law, with respect to Indemnitee’s entitlement thereto shall be made in the specific case (i) if a Change in Control shall
have occurred, by Independent Counsel in a written opinion to the Company’s board of directors, a copy of which shall be delivered to Indemnitee or (ii) if a Change in Control shall not have occurred, (A) by a majority vote of the
Disinterested Directors, even though

  

 -7- 

 
less than a quorum of the Company’s board of directors, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than
a quorum of the Company’s board of directors, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Company’s board of directors, a copy of
which shall be delivered to Indemnitee or (D) if so directed by the Company’s board of directors, by the stockholders of the Company. If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be
made within ten days after such determination. Indemnitee shall cooperate with the person, persons or entity making the determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or
entity upon reasonable advance request any documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or
expenses (including attorneys’ fees and disbursements) reasonably incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company, to the extent permitted by applicable law.

 (c) In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to
Section 10(b), the Independent Counsel shall be selected as provided in this Section 10(c). If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Company’s board of directors, and the Company
shall give written notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request
that such selection be made by the Company’s board of directors, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In
either event, Indemnitee or the Company, as the case may be, may, within ten days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection;
provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 1 of this Agreement, and
the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the
Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within 20 days after the later of (i) submission by Indemnitee
of a written request for indemnification pursuant to Section 10(a) hereof and (ii) the final disposition of the Proceeding, the parties have not agreed upon an Independent Counsel, either the Company or Indemnitee may petition a court of
competent jurisdiction for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and for the appointment as Independent Counsel of a person selected by the court or
by such other person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 10(b) hereof. Upon the due commencement of any
judicial proceeding pursuant to Section 12(a) of this Agreement, the Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then
prevailing). 
  

 -8- 

 (d) The Company agrees to pay the reasonable fees and expenses of any Independent Counsel
and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. 
 11. Presumptions and Effect of Certain Proceedings. 
 (a) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not
(except as otherwise expressly provided in this Agreement) of itself create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or,
with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful. 
 (b) For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith to the extent Indemnitee relied in good faith on (i) the records or books of account of the Enterprise, including financial
statements, (ii) information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, (iii) the advice of legal counsel for the Enterprise or its board of directors or counsel selected by any committee of the
board of directors or (iv) information or records given or reports made to the Enterprise by an independent certified public accountant, an appraiser, investment banker or other expert selected with reasonable care by the Enterprise or its
board of directors or any committee of the board of directors. The provisions of this Section 11(b) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed to have met the applicable
standard of conduct set forth in this Agreement. 
 (c) Neither the knowledge, actions nor failure to act of any other director,
officer, agent or employee of the Enterprise shall be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement. 
 12. Remedies of Indemnitee. 
 (a) Subject to Section 12(d), in the
event that (i) a determination is made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8 or
12(c) of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 10 of this Agreement within 90 days after the later of the receipt by the Company of the request for indemnification
or the final disposition of the Proceeding, (iv) payment of indemnification pursuant to this Agreement is not made (A) within ten days after a determination has been made that Indemnitee is entitled to indemnification or (B) with
respect to indemnification pursuant to Sections 4, 5 and 12(c) of this Agreement, within 30 days after receipt by the Company of a written request therefor, or (v) the Company or any other person or entity takes or threatens to take any
action to declare this Agreement void or unenforceable, or institutes any litigation or other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, Indemnitee
shall be entitled to an adjudication by a court of competent jurisdiction of his or her entitlement to such indemnification or advancement of Expenses. Indemnitee shall commence such proceeding seeking

  

 -9- 

 
an adjudication within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 12(a); provided, however, that
the foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his or her rights under Section 4 of this Agreement. The Company shall not oppose Indemnitee’s right to seek any such adjudication in
accordance with this Agreement. 
 (b) Neither (i) the failure of the Company, its board of directors, any committee or
subgroup of the board of directors, Independent Counsel or stockholders to have made a determination that indemnification of Indemnitee is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor (ii) an
actual determination by the Company, its board of directors, any committee or subgroup of the board of directors, Independent Counsel or stockholders that Indemnitee has not met the applicable standard of conduct, shall be a defense to the action or
create a presumption that Indemnitee has or has not met the applicable standard of conduct. In the event that a determination shall have been made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to indemnification, any
judicial proceeding commenced pursuant to this Section 12 shall be conducted in all respects as a de novo trial, on the merits, and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial
proceeding commenced pursuant to this Section 12, the Company shall, to the fullest extent not prohibited by law, have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.

 (c) To the extent not prohibited by law, the Company shall indemnify Indemnitee against all Expenses that are incurred by
Indemnitee in connection with any action for indemnification or advancement of Expenses from the Company under this Agreement or under any directors’ and officers’ liability insurance policies maintained by the Company to the extent
Indemnitee is successful in such action, and, if requested by Indemnitee, shall (as soon as reasonably practicable, but in any event no later than 30 days, after receipt by the Company of a written request therefor) advance such Expenses to
Indemnitee, subject to the provisions of Section 8. 
 (d) Notwithstanding anything in this Agreement to the contrary, no
determination as to entitlement to indemnification shall be required to be made prior to the final disposition of the Proceeding. 
 13. Contribution. To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee, the Company, in lieu of indemnifying Indemnitee, shall contribute to the
amounts incurred by Indemnitee, whether for Expenses, judgments, fines or amounts paid or to be paid in settlement, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and
reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the events and transactions giving rise to such Proceeding; and (ii) the
relative fault of Indemnitee and the Company (and its other directors, officers, employees and agents) in connection with such events and transactions. 
  

 -10- 

 14. Non-exclusivity. The rights of indemnification and to receive advancement of
Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Company’s certificate of incorporation or bylaws, any agreement, a vote of
stockholders or a resolution of directors, or otherwise. To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the
Company’s certificate of incorporation and bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change, subject to the restrictions expressly
set forth herein or therein. Except as expressly set forth herein, no right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other
right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. Except as expressly set forth herein, the assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent
assertion or employment of any other right or remedy. 
 15. No Duplication of Payments. The Company shall not be liable
under this Agreement to make any payment of amounts otherwise indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received payment for such amounts under any insurance
policy, contract, agreement or otherwise. 
 16. Insurance. To the extent that the Company maintains an insurance policy
or policies providing liability insurance for directors, trustees, general partners, managing members, officers, employees, agents or fiduciaries of the Company or any other Enterprise, Indemnitee shall be covered by such policy or policies to the
same extent as the most favorably-insured persons under such policy or policies in a comparable position. 
 17.
Subrogation. In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary
to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 
 18. Services to the Company. Indemnitee agrees to serve as a director or officer of the Company or, at the request of the Company, as a director, trustee, general partner, managing member, officer,
employee, agent or fiduciary of another Enterprise, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed from such position. Indemnitee may at any time and for any reason resign from
such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee in such position. This Agreement shall not be
deemed an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee. Indemnitee specifically acknowledges that any employment with the Company (or any of its subsidiaries or any Enterprise) is at will, and
Indemnitee may be discharged at any time for any reason, with or without cause, with or without notice, except as may be otherwise expressly provided in any executed, written employment contract between Indemnitee and the Company (or any of its
subsidiaries or any Enterprise), any existing formal severance policies adopted by the Company’s board of directors or, with respect to service as a director or officer of the Company, the Company’s certificate of incorporation or bylaws
or the DGCL. No such document shall be subject to any oral modification thereof. 
  

 -11- 

 19. Duration. This Agreement shall continue until and terminate upon the later of
(a) ten years after the date that Indemnitee shall have ceased to serve as a director or officer of the Company or as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of any other Enterprise, as
applicable; or (b) one year after the final termination of any Proceeding, including any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding
commenced by Indemnitee pursuant to Section 12 of this Agreement relating thereto. 
 20. Successors. This Agreement
shall be binding upon the Company and its successors and assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company, and shall inure to the
benefit of Indemnitee and Indemnitee’s heirs, executors and administrators. 
 21. Severability. Nothing in this
Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law. The Company’s inability, pursuant to court order or other applicable law, to perform its obligations
under this Agreement shall not constitute a breach of this Agreement. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality and
enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal
or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to
applicable law and to give the maximum effect to the intent of the parties hereto; and (iii) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any section of this Agreement
containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. 
 22. Enforcement. The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations
imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company. 
 23. Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter
hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in
furtherance of the Company’s certificate of incorporation and bylaws and applicable law. 
 24. Modification and
Waiver. No supplement, modification or amendment to this Agreement shall be binding unless executed in writing by the parties hereto. No amendment, alteration or repeal of this Agreement shall adversely affect any right of Indemnitee under this
Agreement in respect of any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such amendment, alteration or repeal. No waiver of any of the provisions of this Agreement shall constitute or be deemed a waiver of any
other provision of this Agreement nor shall any waiver constitute a continuing waiver. 
  

 -12- 

 25. Notices. All notices and other communications required or permitted hereunder
shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail or otherwise delivered by hand, messenger or courier service addressed: 
 (a) if to Indemnitee, to Indemnitee’s address, facsimile number or electronic mail address as shown on the signature page of this
Agreement or in the Company’s records, as may be updated in accordance with the provisions hereof; or 
 (b) if to the
Company, to the attention of the Chief Executive Officer or Chief Financial Officer of the Company at 1130 Kifer Road, Sunnyvale, CA 94086, or at such other current address as the Company shall have furnished to Indemnitee, with a copy (which shall
not constitute notice) to Carmen Chang, Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto, California 94304. 
 Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if delivered by hand, messenger or courier service, when delivered
(or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), (ii) if sent via mail, at the earlier of its receipt or five days after
the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via facsimile, upon confirmation of facsimile transfer or, if sent via electronic
mail, when directed to the relevant electronic mail address, if sent during normal business hours of the recipient, or if not sent during normal business hours of the recipient, then on the recipient’s next business day. 
 26. Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and
construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. The Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of
or in connection with this Agreement shall be brought only in the Delaware Court of Chancery, and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive
jurisdiction of the Delaware Court of Chancery for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service of process in the State of
Delaware, Corporation Service Company, Wilmington, Delaware as its agent in the State of Delaware as such party’s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal
force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court of Chancery, and (v) waive, and agree not to
plead or to make, any claim that any such action or proceeding brought in the Delaware Court of Chancery has been brought in an improper or inconvenient forum. 
  

 -13- 

 27. Counterparts. This Agreement may be executed in one or more counterparts, each of
which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature and in counterparts, each of which shall for all
purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this
Agreement. 
 28. Captions. The headings of the paragraphs of this Agreement are inserted for convenience only and shall
not be deemed to constitute part of this Agreement or to affect the construction thereof. 
 (signature page follows)

  

 -14- 

 The parties are signing this Indemnification Agreement as of the date stated in the
introductory sentence. 
  

			
	TELENAV, INC.
	
	  
 (Signature)

	
	  
 (Print name)

	
	  
 (Title)

	
	[INSERT INDEMNITEE NAME]
	
	  
 (Signature)

	
	  
 (Print name and
title of signatory, if applicable)

		
	Address:	 	  

		 	  

		
	E-mail:	 	  

		
	Fax:	 	  

 (Signature page to Indemnification Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00164-of-00352.parquet"}]]